Want to join the conversation?
$XRAY 2Q15 Call: Sales, excluding precious metals, declined 7.7% vs. 2Q14 as internal growth of 3.6% was more than fully offset by negative currency translation of 10.9%. Net acquisition growth was negative 0.4%. Adjusted operating margin for 2Q15 expanded 180 BP to 21.1%. Adjusted EPS was up 6% in 2Q15 despite a significant drag from currency.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.